Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gunnar Lindeberg is active.

Publication


Featured researches published by Gunnar Lindeberg.


Tetrahedron Letters | 1996

Rapid microwave-assisted Suzuki coupling on solid -phase.

Mats Larhed; Gunnar Lindeberg; Anders Hallberg

Abstract Microwave-assisted palladium-catalysed coupling of aryl and heteroaryl boronic acids with iodo- and bromo-substituted benzoic acids, anchored to TentaGel S RAM, provided high isolated yields of coupled products after a reaction time of 3.8 minutes (45 W).


FEBS Letters | 1995

The difference in affinity between two fungal cellulose-binding domains is dominated by a single amino acid substitution

Markus B. Linder; Gunnar Lindeberg; Tapani Reinikainen; Tuula T. Teeri; Göran Pettersson

Cellulose‐binding domains (CBDs) form distinct functional units of most cellulolytic enzymes. We have compared the cellulose‐binding affinities of the CBDs of cellobiohydrolase I (CBHI) and endoglucanase I (EGI) from the fungus Trichoderma reesei. The CBD of EGI had significantly higher affinity than that of CBHI. Four variants of the CBHI CBD were made in order to identify the residues responsible for the increased affinity in EGI. Most of the difference could be ascribed to a replacement of a tyrosine by a tryptophan on the flat cellulose‐binding face.


Bioorganic & Medicinal Chemistry | 2003

Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): A comparative study of different C-terminals

Anja Johansson; Anton Poliakov; Eva Åkerblom; Karin Wiklund; Gunnar Lindeberg; Susanne Winiwarter; U. Helena Danielson; Bertil Samuelsson; Anders Hallberg

Synthesis and inhibitory potencies of three types of protease inhibitors of the hepatitis C virus (HCV) full-length NS3 (protease-helicase/NTPase) are reported: (i) inhibitors comprising electrophilic serine traps (pentafluoroethyl ketones, alpha-keto acids, and alpha-ketotetrazoles), (ii) product-based inhibitors comprising a C-terminal carboxylate group, and (iii) previously unexplored inhibitors comprising C-terminal carboxylic acid bioisosteres (tetrazoles and acyl sulfonamides). Bioisosteric replacement with the tetrazole group provided inhibitors equally potent to the corresponding carboxylates, and substitution with the phenyl acyl sulfonamide group yielded more potent inhibitors. The hexapeptide inhibitors Suc-Asp-D-Glu-Leu-Ile-Cha-Nva-NHSO(2)Ph and Suc-Asp-D-Glu-Leu-Ile-Cha-ACPC-NHSO(2)Ph with K(i) values of 13.6 and 3.8 nM, respectively, were approximately 20 times more potent than the corresponding inhibitors with a C-terminal carboxylate and were comparable to the carboxylate-based inhibitor containing the native cysteine, Suc-Asp-D-Glu-Leu-Ile-Cha-Cys-OH (K(i)=28 nM). The acyl sulfonamide group constitutes a very promising C-terminal functionality that allows for prime site optimization.


FEBS Letters | 1989

Isolated fungal cellulose terminal domains and a synthetic minimum analogue bind to cellulose

Gunnar Johansson; Jerry Ståhlberg; Gunnar Lindeberg; Åke Engström; Göran Pettersson

The cellulose‐binding properties of the highly conserved terminal region which is common to several fungal cellulases were studied. Domains were prepared by proteolytic cleavage of Trichoderma reesei CBH1 and the corresponding enzyme from Sporotrichum pulverulentum, and a peptide corresponding to residues 462–497 (the C‐terminal part) of Trichoderma CBH1 was synthesized. The three peptides showed similar binding behavior, whereas reduced and S‐carboxymethylated T. reesei fragment was inactive. This region thus appears to serve as an independent functional domain in which the C‐terminal part is responsible for the binding, which in turn requires an intact three‐dimensional structure.


Biochemical and Biophysical Research Communications | 1976

Opiate receptor affinity of peptides related to Leu-enkephalin.

Lars Terenius; A. Wahlström; Gunnar Lindeberg; Sune M. Karlsson; Ulf Ragnarsson

Abstract Several analogs of Leu-enkephalin were synthesized by the standard solid phase procedure in order to investigate structural requirements for binding to opiate receptors. Decisive features for receptor interaction seem to be the presence and location of the aromatic side chains of the tyrosine and phenylalanine residues. The terminal amino and carboxyl groups do not contribute significantly to binding affinity.


European Journal of Pharmacology | 1997

Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes.

Helgi B. Schiöth; Ruta Muceniece; Monika Larsson; Felikss Mutulis; Peteris Prusis; Gunnar Lindeberg; Jarl E. S. Wikberg

We report here the binding of 5-, 6- and 7-amino-acid-long linear and cyclic core peptides of MSH (melanocyte-stimulating hormone) to cells transiently expressing the human melanocortin MC1, MC3, MC4 and MC5 receptors. The results show that, in contrast to the natural peptides, the core peptides did not differentiate between the melanocortin MC3 and MC4 receptors. All tested cyclic peptides had much lower affinities than their corresponding linear homologues. Interestingly, the relative loss of binding due to the cyclisation did not change as the ring size decreased. Therefore, decreasing the ring size does not seem to force the peptide into a more unfavourable conformation.


Bioorganic & Medicinal Chemistry | 2002

Tetrapeptides as Potent Protease Inhibitors of Hepatitis C Virus Full-Length NS3 (Protease-Helicase/NTPase)

Anja Johansson; Anton Poliakov; Eva Åkerblom; Gunnar Lindeberg; Susanne Winiwarter; Bertil Samuelsson; U. Helena Danielson; Anders Hallberg

A library of tetrapeptides was evaluated for Hepatitis C Virus NS3 protease inhibitor activity in an in vitro assay system comprising the native bifunctional full-length NS3 (protease-helicase/NTPase) protein. Tetrapeptides with K(i) values in the high nanomolar range were identified, for example Suc-Chg-Glu-2-Nal-Cys (K(i)=0.27+/-0.03 microM) and Suc-Dif-Glu-Glu-Cys (K(i)=0.40+/-0.10 microM). Furthermore, it was shown that the inhibitory potencies are not affected significantly by assay ionic strength. As suggested by molecular modelling, potential binding interactions of the tetrapeptide inhibitors with the helicase domain might explain the data and structure-activity relationships thus obtained. Hence, we postulate that the full-length NS3 assay is a relevant system for inhibitor identification, offering new opportunities for inhibitor design.


Journal of Chromatography A | 1992

Immobilized metal ion affinity chromatography of synthetic peptides: Binding via the α-amino group

Par Hansen; Gunnar Lindeberg; Lennart Andersson

Peptides synthesized by the solid-phase method can be efficiently purified in a single immobilized metal affinity chromatography step based on interaction with the alpha-amino group if, after coupling of each amino acid residue, unreacted amino groups are irreversibly blocked by acetylation and if no strongly metal-binding amino acids (His, Trp, Cys) are present in the sequence. A difference in basicity for alpha- and epsilon-amino functions of ca. 2 pH units is sufficiently large to allow selective binding of peptides to immobilized metal ions via the unprotonated alpha-amino group. The binding is pH-dependent: on Cu(2+)- and Ni(2+)-loaded supports most peptides are maximally retarded at pH values around 7.5 and 8.5, respectively. The decreased binding strength at lower pH values is due to protonation of the alpha-amino function, whereas the reduced affinity at higher pH is caused by metal ion transfer from the matrix to the peptide. The metal ion is captured in a multidentate chelate where, in addition to the alpha-amino group, up to three adjacent deprotonated amide nitrogens are coordinated to the metal. If the pH is raised further, additional metal ions may be bound in biuret-like structures. Immobilized Ni2+, owing to its higher selectivity and affinity, is the preferred chromatographic support if slightly basic conditions can be tolerated.


Bioorganic & Medicinal Chemistry Letters | 2001

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.

Anja Johansson; Ina Hubatsch; Eva Åkerblom; Gunnar Lindeberg; Susanne Winiwarter; U. Helena Danielson; Anders Hallberg

Structure activity relationships (SARs) of product-based inhibitors of hepatitis C virus NS3 protease were evaluated using an in vitro assay system comprising the native bifunctional full-length NS3 (protease-helicase/NTPase). The results were compared to previously reported data derived from the corresponding NS3 protease domain assay. Shortening the length of the protease inhibitors from hexapeptides to tripeptides revealed that the decrease in potency was much less when determined in the assay system with the full-length NS3 protein. Disagreements in SARs at different positions (P5 P2) were also discovered. Taken together, the results suggest that the impact of the helicase domain upon protease inhibitor binding is substantial.


Journal of Medicinal Chemistry | 2010

Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP)

Heidi Demaegdt; Georges Vauquelin; Gunnar Lindeberg; Anders Karlén; Mathias Hallberg; Máté Erdélyi; Anders Hallberg

The insulin-regulated aminopeptidase (IRAP) localized in areas of the brain associated with memory and learning is emerging as a new promising therapeutic target for the treatment of memory dysfunctions. The angiotensin II metabolite angiotensin IV (Ang IV, Val(1)-Tyr(2)-Ile(3)-His(4)-Pro(5)-Phe(6)) binds with high affinity to IRAP and inhibits this aminopeptidase (K(i) = 62.4 nM). Furthermore, Ang IV has been demonstrated to enhance cognition in animal models and is believed to play an important role in cognitive processes. It is herein reported that displacement of the C-terminal tripeptide His(4)-Pro(5)-Phe(6) with a phenylacetic acid functionality combined with a constrained macrocyclic system in the N-terminal affords potent IRAP inhibitors that are less peptidic in character than the hexapeptide Ang IV. Configurational analysis of three pairs of diastereomeric Ang IV analogues was performed using a combination of solution NMR spectroscopic methods, Monte Carlo conformational searches, and NAMFIS calculations. The compounds encompassing l-amino acids only (4, 8, and 12) showed significantly higher bioactivity compared to their lld-epimers (5, 9, and 13). The best inhibitors in the series, compounds 8 and 12, incorporating a 13- and 14-membered disulfide ring system, respectively, and both with a β(3)-homotyrosine residue (β(3)hTyr) replacing Tyr(2), exhibit K(i) values of 3.3 and 5.2 nM, respectively.

Collaboration


Dive into the Gunnar Lindeberg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge